Accendra Health, Inc.
Here’s whether Accendra Health, Inc. (ACH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.30% over 10 days); RSI 14 — oversold; 3-month momentum negative (-67.3%); rising volume on a downtrend (distribution, 2.16x avg). Currently 79.7% off its 52-week high. Score: -4/7.
ACH is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 14.4 has dropped into oversold territory, which has historically preceded short-term bounces. With ~7 months of trading history, the return since first available bar is -59.0%. The current 79.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.